References
- Beasley W. C. Quantitative muscle testing: principles and applications to research and clinical services. Arch Phys Med Rehabil 1961; 42: 398–425
- Schiffman P. L., Belsh J. M. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest 1993; 103: 5008–13
- Mier A. Respiratory muscle weakness. Resp Med 1990; 84: 351–9
- Fallat R. J., Norris F. H., Holden D., Kandal K., Roggero P. C. Respiratory monitoring and treatment: objective treatments using non‐invasive measurements. Amyotrophic Lateral Sclerosis: Therapeutic, Psychological, and Research Aspects. Adv Exper Med & Biol, V Cosi, A. C Kato, W Parlette, P Pinelli, M Poloni, 1989; 191–200, Vol 209
- Goldstein R. S. Hypoventilation. Neuromuscular and chest wall disorders. Clin Chest Med 1992; 13: 507–21
- Medicare Durable Medical Equipment Regional Carrier's (DMERC) medical policy for Respiratory Assist Devices. Region D Supplier Manual, Oct 1, 1999
- Miller R. G., Rosenberg J. A., Gelinas D. F., Mitsumoto H., Newman D., Sufit R. Practice Parameter. The care of the patient with amyotrophic lateral sclerosis (an evidence based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1999; 52: 1311–23
- Ringel S. P., Murphy J. R., Alderson M. K., Bryan W., England J. D., Miller R. G. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–22
- Brinkman J. R., Andres P., Mendoza M., Sanjak M. Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials. J Neurol Sci 1997; 147: 97–111
- Shneerson J. M., Simmonds A. K. Non‐invasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002; 20: 480–7
- Anderson P. M., Borasio G. D., Dengler R., Hardiman O., Kollewe K., Leigh N., et al. EFNS Task Force on Management of Amyotrophic Lateral Sclerosis: Guidelines for Diagnosing and Clinical Care of Patients and Relatives. Eur J Neurol 2005; 12: 921–38
- Morgan R., McNally S., Alexander M., Conroy R., Hardiman O., Costello R. Use of sniff nasal inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171: 269–74
- Lyall R. A., Donaldson N., Polkey M. I., Leigh P. N., Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124: 2000–13
- Bourke S. C., Tomlinson M., Williams T. L., Bullock R. E., Shaw P. J., Gibson G. J. Effects of non‐invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurology 2006; 5: 140–7
- Rinqvist T. The ventilatory capacity in healthy patients: an analysis of causal factors with special relevance to respiratory forces. Scan J Clin Lab Inves 1966; 18((Suppl 88))8–170
- Black L. F., Hyatt R. E. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis 1971; 103: 641–50
- Harik‐Khan R. I., Wise R. A., Fozard J. L. Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998; 158: 1459–64
- Wen A., Woo M., Keens T. Pulmonary physiologic test of the month: how many maneuvers are required to measure maximal inspiratory pressure accurately?. Chest 1997; 111: 802–7
- Larson J. L., Covey M. K., Vitalo C. A., Alex C. G., Patel M., Kim M. J. Maximal inspiratory pressure. Learning effect and test‐retest reliability in patients with chronic obstructive pulmonary disease. Chest 1993; 104: 448–53
- Mendoza M., Moore, Gelinas D., Miller R. G., the WALS Group. Variability of maximal inspiratory pressure testing in amyotrophic lateral sclerosis. Abstract. 12th International Symposium on ALS/MND. Amyotroph Lateral Scler Other Motor Neuron Dis 2001; 2: 82